SI1861405T1 - Postopek za zmanjšanje alfa,beta-nenasičenih ketonov v opioidnih sestavkih - Google Patents

Postopek za zmanjšanje alfa,beta-nenasičenih ketonov v opioidnih sestavkih

Info

Publication number
SI1861405T1
SI1861405T1 SI200630344T SI200630344T SI1861405T1 SI 1861405 T1 SI1861405 T1 SI 1861405T1 SI 200630344 T SI200630344 T SI 200630344T SI 200630344 T SI200630344 T SI 200630344T SI 1861405 T1 SI1861405 T1 SI 1861405T1
Authority
SI
Slovenia
Prior art keywords
beta
unsaturated ketones
reducing alpha
opioid compositions
reducing
Prior art date
Application number
SI200630344T
Other languages
English (en)
Inventor
Robert J Kupper
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of SI1861405T1 publication Critical patent/SI1861405T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
SI200630344T 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa,beta-nenasičenih ketonov v opioidnih sestavkih SI1861405T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65879105P 2005-03-04 2005-03-04
EP06707309A EP1861405B1 (en) 2005-03-04 2006-02-27 Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Publications (1)

Publication Number Publication Date
SI1861405T1 true SI1861405T1 (sl) 2009-10-31

Family

ID=36301669

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200630344T SI1861405T1 (sl) 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa,beta-nenasičenih ketonov v opioidnih sestavkih
SI200630885T SI2112153T1 (sl) 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa, beta-nenasičenih ketonov v opioidnih sestavkih

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200630885T SI2112153T1 (sl) 2005-03-04 2006-02-27 Postopek za zmanjšanje alfa, beta-nenasičenih ketonov v opioidnih sestavkih

Country Status (19)

Country Link
US (1) US7939543B2 (sl)
EP (2) EP1861405B1 (sl)
JP (1) JP5314894B2 (sl)
KR (1) KR100941761B1 (sl)
CN (1) CN101133062B (sl)
AT (2) ATE430153T1 (sl)
CA (1) CA2598774C (sl)
CY (2) CY1109262T1 (sl)
DE (2) DE602006018208D1 (sl)
DK (2) DK1861405T3 (sl)
ES (2) ES2326491T3 (sl)
HK (2) HK1111695A1 (sl)
HR (2) HRP20090387T1 (sl)
ME (2) ME01184B (sl)
PL (2) PL1861405T3 (sl)
PT (2) PT2112153E (sl)
RS (2) RS51568B (sl)
SI (2) SI1861405T1 (sl)
WO (1) WO2006094672A1 (sl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070183980A1 (en) * 2003-08-06 2007-08-09 Elisabeth Arkenau-Maric Dosage form that is safeguarded from abuse
US20070048228A1 (en) * 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
TWI365880B (en) 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007103105A2 (en) * 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
WO2008070658A1 (en) * 2006-12-04 2008-06-12 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
ES2378710T3 (es) * 2006-12-04 2012-04-17 Noramco, Inc. Procedimiento para reducir impurezas en la base de oxicodona
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
CA2684458A1 (en) 2007-04-16 2008-10-30 Mallinckrodt Inc. Novel opiate reduction utilizing catalytic hydrogen transfer reaction
FR2923484B1 (fr) * 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
US8377453B2 (en) * 2008-03-11 2013-02-19 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) * 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
WO2009135680A1 (en) 2008-05-09 2009-11-12 Grünenthal GmbH Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
CN102639118B (zh) 2009-07-22 2015-07-29 格吕伦塔尔有限公司 氧化稳定的抗干扰剂型
ES2534908T3 (es) * 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
KR20120059582A (ko) * 2009-08-31 2012-06-08 데포메드 인코퍼레이티드 아세트아미노펜의 속방성 및 서방성을 위한 위 체류 약제학적 조성물
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2377866B1 (en) 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
ES2666404T3 (es) 2010-06-11 2018-05-04 Rhodes Technologies Procesos catalizados por metales de transición para la preparación de compuestos de N-alilo y uso de los mismos
WO2011154826A1 (en) 2010-06-11 2011-12-15 Rhodes Technologies Process for n-dealkylation of tertiary amines
PL2611426T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
DK2736495T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel
EP2819656A1 (en) 2012-02-28 2015-01-07 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
MX362357B (es) 2012-04-18 2019-01-14 Gruenenthal Gmbh Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9127008B2 (en) 2013-03-15 2015-09-08 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
AU2014273226B2 (en) 2013-05-29 2019-06-27 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
BR112016010482B1 (pt) 2013-11-26 2022-11-16 Grünenthal GmbH Preparação de uma composição farmacêutica em pó por meio de criomoagem
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
MA40332A (fr) 2014-07-09 2021-04-28 Rhodes Tech Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane
CA2983642A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812312A (en) 1971-11-15 1974-05-21 Chrysler Corp Impact velocity sensor switch with linearly movable controller
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TWI365880B (en) * 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp

Also Published As

Publication number Publication date
CN101133062B (zh) 2014-08-06
HK1135107A1 (en) 2010-05-28
HRP20090387T1 (en) 2009-08-31
CY1111241T1 (el) 2015-06-11
EP2112153B1 (en) 2010-11-10
RS51568B (en) 2011-08-31
CA2598774A1 (en) 2006-09-14
HRP20110078T1 (hr) 2011-03-31
ES2326491T3 (es) 2009-10-13
ME01594B (me) 2014-09-20
RS51131B (sr) 2010-10-31
DK2112153T3 (da) 2011-02-14
PL1861405T3 (pl) 2009-10-30
ME01184B (me) 2013-03-20
DE602006006558D1 (de) 2009-06-10
SI2112153T1 (sl) 2011-02-28
JP5314894B2 (ja) 2013-10-16
EP1861405A1 (en) 2007-12-05
ATE487722T1 (de) 2010-11-15
PT2112153E (pt) 2010-12-17
EP2112153A1 (en) 2009-10-28
KR100941761B1 (ko) 2010-02-11
CY1109262T1 (el) 2014-07-02
DE602006018208D1 (de) 2010-12-23
ATE430153T1 (de) 2009-05-15
CN101133062A (zh) 2008-02-27
HK1111695A1 (en) 2008-08-15
EP1861405B1 (en) 2009-04-29
KR20070108931A (ko) 2007-11-13
PL2112153T3 (pl) 2011-04-29
US20080132702A1 (en) 2008-06-05
DK1861405T3 (da) 2009-07-20
ES2355870T3 (es) 2011-03-31
WO2006094672A1 (en) 2006-09-14
CA2598774C (en) 2010-12-21
PT1861405E (pt) 2009-07-27
JP2008531626A (ja) 2008-08-14
US7939543B2 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
HK1135107A1 (en) Method of reducing alpha, beta- unsaturated ketones in opioid compositions
WO2007103105A3 (en) Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
TW200736256A (en) Process for the preparation of substituted heterocycles
EA201100748A1 (ru) Пиразиновые соединения в качестве ингибиторов фосфодиэстеразы 10
EP1938892A4 (en) SOLID DEOXYGENANT COMPOSITION AND METHOD FOR MANUFACTURING THE SAME
NZ602862A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
WO2011060304A3 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
MY150082A (en) Trans-clomiphene for metabolic syndrome
IL227565A (en) Salts of hexahydropananthridine preserved in position 5 of the heterocyclic group and pharmaceutical preparations containing them
DK2044067T3 (da) Fremgangsmåde til fremstilling af 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octanbromid
TW200700071A (en) Novel use
MX2011008885A (es) Composiciones, sintesis y metodos para usar derivados de arilpiperazina.
EP1942170A4 (en) ACCELERATORS FOR OZONE OXIDATION, OZONE OXIDIZING COMPOUND COMPOSITION, AND OZONE PROCESSING
ATE524427T1 (de) Verfahren zur herstellung von 3-methyl-1,5- pentandiol
WO2009154993A8 (en) Compositions, synthesis, and methods of using piperazine based antipsychotic agents
ATE452117T1 (de) Verfahren zur herstellung von cyclischen ketonen
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
MX2011006845A (es) Inhibidores de glyt1 biciclicos 3.1.0 y metodos para elaboracion y utilizacion de los mismos.
ATE511760T1 (de) Nuss-stückchen enthaltendes kaugummi
WO2009112709A3 (fr) Nouveau procede pour la preparation d'extraits de ginkgo biloba
WO2008011161A3 (en) Dermal anesthetic compounds
MX2009003200A (es) Procedimiento para la preparacion de pradofloxacino.
WO2008080120A3 (en) 3-amino chromane derivatives